Results 61 to 70 of about 130,082 (182)
Biomarkers of native liver survival and portal hypertension in biliary atresia
Abstract Objective To evaluate the prognostic value of noninvasive markers Aspartate Aminotransferase to Platelet Ratio Index (APRi) and Infantile Biliary Atresia Liver Fibrosis score (iBALF), as well as the histological Ishak fibrosis score, as predictors of native liver survival (NLS) and portal hypertension (PH) in children with biliary atresia (BA)
Karyne Sumico de Lima Uyeno Jordão +2 more
wiley +1 more source
Congenital short bowel syndrome: Clinical aspects by systematic review
Abstract Objectives Congenital short bowel syndrome (CSBS) is a rare intestinal disorder characterized by inborn shortening of the bowel with mainly mutations in Coxsackie and Adenovirus receptor‐like membrane protein (CLMP) and Filamin A (FLNA) genes.
Barblin Remund +2 more
wiley +1 more source
Abstract Thiopurines, such as azathioprine (AZA), are among the immunosuppressants used to prevent allograft rejection. Thiopurines are metabolized by thiopurine S‐methyltransferase (TPMT) and nudix hydrolase 15 (NUDT15) enzymes, and their functions are highly influenced by genetic variation. We present a 6‐year‐old female with recurrent acute cellular
Jenny Q. Nguyen +4 more
wiley +1 more source
Biliary atresia in a 65-day-old girl.
(A) US image in transverse plane shows negative triangular cord sign (arrow). (B) US image in oblique subcostal plane shows atretic gallbladder measuring 0.8 cm (asterisk) and enlarged hepatic artery measuring 1.5 mm (arrow).
Sook Min Hwang (2266987) +7 more
core +1 more source
Clinical and demographic data of the studied biliary atresia patients.
Clinical and demographic data of the studied biliary atresia patients.
Wison Laochareonsuk (8209470) +3 more
core +1 more source
Diffuse gallbladder epithelial proliferation after teduglutide exposure: A case report
Abstract Teduglutide, a glucagon‐like peptide 2 analog that increases mucosal proliferation in the gastrointestinal tract, was approved by the U.S. Food and Drug Administration for use in children with intestinal failure in 2019 after trials of 12‐ and 24‐week duration.
Christopher P. Duggan +4 more
wiley +1 more source
Pediatric biliary atresia: Prenatal and postnatal risk factors [PDF]
Background: Biliary atresia is the most common cause of cholestasis in infants caused by intrauterine and neonatal inflammatory process leads to progressive biliary tract obstruction and fibrosis.
Dina Aristiya Sumarno, - +2 more
core +1 more source
We describe the rare instance of concomitant biliary atresia and alpha-1-antitrypsin deficiency and the first documented successful portoenterostomy in this scenario.
Andrew W. Wang +2 more
doaj +1 more source
ABSTRACT This retrospective study aimed to explore the value of DAT‐FAT serological profiles confirmed by AET in classifying neonatal jaundice, evaluating its severity, and guiding clinical management. A total of 915 jaundiced newborns (584 pathological, 331 physiological) admitted from July 2018 to August 2021 were included.
Tian‐Ge Wu +7 more
wiley +1 more source
ABSTRACT Sex chromosome aneuploidies represent a heterogeneous group of chromosomal conditions, in which phenotypic complexity generally increases with the number of supernumerary sex chromosomes. While Turner syndrome and sex chromosome trisomies are relatively well characterized, less is known about congenital malformations in sex chromosome ...
Anna Colding +3 more
wiley +1 more source

